NEW YORK (GenomeWeb) – Molecular diagnostics firm Paradigm announced today that it has signed a deal under which its PCDx next-generation sequencing-based cancer test will be covered by health insurer Three Rivers Provider Network.

According to Paradigm, Three Rivers has more than 15 million US members.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.